These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
325 related items for PubMed ID: 32733659
1. Inequities in the use of sulphadoxine-pyrimethamine for malaria prophylaxis during pregnancy in Nigeria. Ndu A, Mbachu C, Anitube O, Ezeoke U. Malawi Med J; 2020 Mar; 32(1):45-51. PubMed ID: 32733659 [Abstract] [Full Text] [Related]
2. Uptake of intermittent preventive treatment for malaria during pregnancy with Sulphadoxine-Pyrimethamine in Malawi after adoption of updated World Health Organization policy: an analysis of demographic and health survey 2015-2016. Azizi SC. BMC Public Health; 2020 Mar 16; 20(1):335. PubMed ID: 32178658 [Abstract] [Full Text] [Related]
3. Predictors for the uptake of optimal doses of sulfadoxine-pyrimethamine for intermittent preventive treatment of malaria during pregnancy in Tanzania: further analysis of the data of the 2015-2016 Tanzania demographic and health survey and malaria indicator survey. Mushi V, Mbotwa CH, Zacharia A, Ambrose T, Moshi FV. Malar J; 2021 Feb 06; 20(1):75. PubMed ID: 33549094 [Abstract] [Full Text] [Related]
5. Decomposition of socioeconomic inequalities in the uptake of intermittent preventive treatment of malaria in pregnancy in Nigeria: evidence from Demographic Health Survey. Okoli CI, Hajizadeh M, Rahman MM, Khanam R. Malar J; 2021 Jul 03; 20(1):300. PubMed ID: 34217299 [Abstract] [Full Text] [Related]
6. Effect of group versus individual antenatal care on uptake of intermittent prophylactic treatment of malaria in pregnancy and related malaria outcomes in Nigeria and Kenya: analysis of data from a pragmatic cluster randomized trial. Noguchi L, Grenier L, Kabue M, Ugwa E, Oyetunji J, Suhowatsky S, Onguti B, Orji B, Whiting-Collins L, Adetiloye O. Malar J; 2020 Jan 29; 19(1):51. PubMed ID: 31996209 [Abstract] [Full Text] [Related]
8. Factors affecting uptake of ≥ 3 doses of Sulfadoxine-Pyrimethamine for malaria prevention in pregnancy in selected health facilities, Arusha region, Tanzania. Mchwampaka WM, Tarimo D, Chacky F, Mohamed A, Kishimba R, Samwel A. BMC Pregnancy Childbirth; 2019 Nov 27; 19(1):440. PubMed ID: 31775686 [Abstract] [Full Text] [Related]
9. Barriers to and determinants of the use of intermittent preventive treatment of malaria in pregnancy in Cross River State, Nigeria: a cross-sectional study. Ameh S, Owoaje E, Oyo-Ita A, Kabiru CW, Akpet OEO, Etokidem A, Enembe O, Ekpenyong N. BMC Pregnancy Childbirth; 2016 May 04; 16():99. PubMed ID: 27147109 [Abstract] [Full Text] [Related]
10. Late ANC initiation and factors associated with sub-optimal uptake of sulphadoxine-pyrimethamine in pregnancy: a preliminary study in Cape Coast Metropolis, Ghana. Amoako BK, Anto F. BMC Pregnancy Childbirth; 2021 Feb 02; 21(1):105. PubMed ID: 33530957 [Abstract] [Full Text] [Related]
11. Factors associated with uptake of optimal doses of intermittent preventive treatment for malaria among pregnant women in Uganda: analysis of data from the Uganda Demographic and Health Survey, 2016. Okethwangu D, Opigo J, Atugonza S, Kizza CT, Nabatanzi M, Biribawa C, Kyabayinze D, Ario AR. Malar J; 2019 Jul 26; 18(1):250. PubMed ID: 31349829 [Abstract] [Full Text] [Related]
12. Antenatal care visit attendance, intermittent preventive treatment and bed net use during pregnancy in Gabon. Bouyou-Akotet MK, Mawili-Mboumba DP, Kombila M. BMC Pregnancy Childbirth; 2013 Feb 26; 13():52. PubMed ID: 23442536 [Abstract] [Full Text] [Related]
13. An ethnographic study of how health system, socio-cultural and individual factors influence uptake of intermittent preventive treatment of malaria in pregnancy with sulfadoxine-pyrimethamine in a Ghanaian context. Aberese-Ako M, Magnussen P, Ampofo GD, Gyapong M, Ansah E, Tagbor H. PLoS One; 2021 Feb 26; 16(10):e0257666. PubMed ID: 34618812 [Abstract] [Full Text] [Related]
14. Determinants of the optimal uptake of sulfadoxine-pyrimethamine doses for intermittent treatment of malaria in pregnancy in urban Nigeria. Adeojo OS, Fayehun O. Sci Rep; 2024 Aug 17; 14(1):19097. PubMed ID: 39154035 [Abstract] [Full Text] [Related]
16. Effectiveness of antenatal clinics to deliver intermittent preventive treatment and insecticide treated nets for the control of malaria in pregnancy in Kenya. Hill J, Dellicour S, Bruce J, Ouma P, Smedley J, Otieno P, Ombock M, Kariuki S, Desai M, Hamel MJ, ter Kuile FO, Webster J. PLoS One; 2013 Aug 17; 8(6):e64913. PubMed ID: 23798997 [Abstract] [Full Text] [Related]
17. Determinants of intermittent preventive treatment of malaria among women attending antenatal clinics in primary health care centers in Ogbomoso, Oyo State, Nigeria. Adewole AO, Fawole O, Ajayi I, Yusuf B, Oladimeji A, Waziri E, Nguku P, Ajumobi O. Pan Afr Med J; 2019 Aug 17; 33():101. PubMed ID: 31489079 [Abstract] [Full Text] [Related]
18. The readiness of malaria services and uptake of intermittent preventive treatment in pregnancy in six sub-Saharan countries. Xu X, Liang D, Zhao J, Mpembeni R, Olenja J, Yam EL, Huang J. J Glob Health; 2024 Jun 28; 14():04112. PubMed ID: 38939971 [Abstract] [Full Text] [Related]
19. Characteristics of Nigerian women taking sulfadoxine/pyrimethamine twice during pregnancy for the prevention of malaria. Onyeneho NG, Orji BC, Okeibunor JC, Brieger WR. Int J Gynaecol Obstet; 2013 Nov 28; 123(2):101-4. PubMed ID: 24041469 [Abstract] [Full Text] [Related]
20. The demand for intermittent preventive treatment of malaria in pregnancy using sulfadoxine-pyrimethamine in the Volta Region of Ghana. Asem L, Abdulia AG, Assuming PO, Abeka-Nkrumah G. PLoS One; 2024 Nov 28; 19(9):e0308321. PubMed ID: 39236029 [Abstract] [Full Text] [Related] Page: [Next] [New Search]